Xenofon Baraliakos
A leading authority on inflammatory diseases
Best podcasts with Xenofon Baraliakos
Ranked by the Snipd community
Aug 12, 2024 • 22min
Discussing AxSpA: Upadacitinib in nr-axSpA and certolizumab pegol by baseline MRI and CRP status
Join Professors Hideto Kameda and Xenofon Baraliakos for insights on upadacitinib in nr-axSpA and certolizumab pegol treatment. Topics include results from a phase 3 trial, analysis of upadacitinib treatment, longer-term safety analysis, clinical outcomes of certolizumab pegol, and response rates based on MRI and CRP status in nr-axSpA patients.
